Scientists use drug to unravel Insulin's secrets in prediabetes
NCT ID NCT06354088
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how the hormone insulin controls blood sugar and fat in healthy adults and those at risk for type 2 diabetes. Researchers will give participants a single dose of a drug called alpelisib, which blocks some of insulin's effects, to see if the liver can still make fat even when it stops responding to insulin's sugar-lowering signal. The goal is to better understand insulin resistance and related conditions like prediabetes and fatty liver disease.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INSULIN RESISTANCE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Columbia University Irving Medical Center
RECRUITINGNew York, New York, 10032, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Daily pill could offer new hope for weight loss in east asian adults
- Can a Boron-Based pill tame obesity and blood sugar?
- Can a traditional herbal remedy tame type 2 diabetes?
- Could immune cells in fat hold the key to Obesity-Related disease?
- Citrus flavonoid hesperidin put to the test as a brain booster for overweight adults
- Can decades of lifting weights keep the Brain's muscle signals young?